TY - JOUR AU - Schuette, Wolfgang AU - Schirmacher, Peter AU - Eberhardt, Wilfried E. E. AU - Dietel, Manfred AU - Zirrgiebel, Ute AU - Muehlenhoff, Lars AU - Thomas, Michael PY - 2018 DA - 2018/02/05 TI - Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study JO - BMC Cancer SP - 135 VL - 18 IS - 1 AB - We evaluated treatment decisions and outcomes in a cohort of predominately Caucasian patients with EGFR mutation-positive (EGFR Mut+) non-small-cell lung cancer (NSCLC). SN - 1471-2407 UR - https://doi.org/10.1186/s12885-018-4032-3 DO - 10.1186/s12885-018-4032-3 ID - Schuette2018 ER -